Redfund Signs Swiss Client Hempfy


Vancouver, British Columbia, July 22, 2020 – Redfund Capital Corp. (CSE: LOAN) (Frankfurt:O3X4) (OTC QB: PNNRF) (Redfund Capital or the “Company”) is pleased to announce a distribution agreement with Hempfy Switzerland to market and distribute their products in North America, New Zealand and Australia. The Hempfy website

Redfund Capital and Tellement Facile SA under the trade name “Hempfy” have signed a distribution agreement for the North American markets of Canada and USA plus New Zealand and Australia. The term is to be 2 years and to be automatically renewed for successive two 2 years terms thereafter.

Hempfy products are 100% legal in most jurisdictions with no THC and no CBD. Hempfy drinks have been specially developed for those, who appreciate the unique taste of cannabis. The drink flavors Cannabis Bitter Lime and Cannabis Sweet Lime draw their unique taste from the hemp infusion. The new Hempfy natural chewing gum, is chicle-based, biodegradable, nature-friendly, sugar-free, vegan friendly + non-GMO. Hempfy focuses on innovative foods and beverages, based on proprietary cold infusion technology for harvesting and processing THC-free cannabis plants, compliant with Swiss legislation. All the products are 100% Swiss made from growing Hemp, producing and developing all products exclusively in Switzerland. Hempfy considers it the “Swiss way of doing things”.

Meris Kott CEO commented, “This Global Wellness initiative began over 2 years ago in Geneva when we met the principles of Hempfy and we have continued following their tremendous organic growth. Seed to sale companies vertically integrated are very rare and Hempfy’s success is due to the total commitment of their team to all details in producing their products. Our distribution channels currently developed at Redfund should enable Hempfy to be on new shelves first in North America very quickly. ”

About Redfund Capital Corp.
Redfund partners with first mover, high growth companies, and provides them with access to capital, resources, and infrastructure. The present focus of the merchant bank is on global wellness, hemp and CBD-related, healthcare-related target companies.

For further information please visit
For more information on Redfund Capital Corp. contact
Meris Kott CEO 604.484.0355 or [email protected]

Further information about the Company is available on under the Company’s profile.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. Certain statements contained in this release may constitute “forward–looking statements” or “forward-looking information” (collectively “forward-looking information”) as those terms are used in the Private Securities Litigation Reform Act of 1995 and similar Canadian laws. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated”, “anticipates” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the business of the Company, the Property, financing and certain corporate changes. The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.